+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced cell therapy for ischemic heart disease

Enhanced cell therapy for ischemic heart disease

Transplantation 86(9): 1151-1160

Stem cell therapy is regarded as an innovative strategy to intervene in degenerative heart disease. The efficacy of stem cell therapy to regenerate ischemic myocardium has been limited by inadequate numbers of injected cells, unacceptable cell engraftment or long-term survival, and from restrictions associated with the method of delivery. In this review, we provide an overview of the literature emphasizing several strategies which enable improved results after cell therapy for ischemic heart disease. Enhanced cell therapy includes (a) combination of cell grafts either pre-co-cultured or co-injected cells, (b) transplantation of genetically modified cells, or (c) simultaneous administration of control released growth factors, (d) cell preconditioning, (e) use of adjunctive systemic therapy, or (f) repetitive cell therapy. Future studies should focus on the development of strategies for optimization of cell delivery, which will enable easy isolation of adequate cell volume and optimal functional results.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982649

Download citation: RISBibTeXText

PMID: 19005393

DOI: 10.1097/TP.0b013e3181880f9e

Related references

Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure. Expert Opinion on Biological Therapy 12(12): 1563-1573, 2013

Cell therapy for ischemic heart disease. Archivos de Cardiologia de Mexico 82(3): 218-229, 2012

Stem cell therapy for ischemic heart disease. Antioxidants & Redox Signaling 13(12): 1879-1897, 2011

Stem cell therapy for ischemic heart disease: where are we?. Current Opinion in Organ Transplantation 14(1): 79-84, 2009

Stem cell therapy for ischemic heart disease. Trends in Molecular Medicine 9(10): 436-441, October, 2003

Cell therapy in treatment of ischemic heart disease. Vestnik Khirurgii Imeni I. I. Grekova 166(1): 106-111, 2007

Stem cell therapy in ischemic heart disease. Cardiovascular Drug Reviews 21(4): 327-342, 2003

Cell- and gene therapy for ischemic heart disease. Minerva Cardioangiologica 53(4): 265-273, 2005

Stem cell-based therapy for ischemic heart disease. Cell Transplantation 22(4): 663-675, 2014

Mesenchymal stromal cell therapy in ischemic heart disease. Scandinavian Cardiovascular Journal 50(5-6): 293-299, 2016

Cell therapy for the treatment of chronic ischemic heart disease. Current Pharmaceutical Design 17(30): 3308-3327, 2012

Progenitor cell therapy of ischemic heart disease: the new frontier. Future Cardiology 1(1): 87-98, 2005

Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network. Jacc. Cardiovascular Imaging 4(6): 671-679, 2012

Comparison between ischemic and non-ischemic heart disease in carvedilol therapy for chronic heart failure. Journal of Heart & Lung Transplantation 19(1): 74, 2000